BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

808 related articles for article (PubMed ID: 33188158)

  • 1. LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA.
    Chen M; Zhang R; Lu L; Du J; Chen C; Ding K; Wei X; Zhang G; Huang Y; Hou J
    Aging (Albany NY); 2020 Nov; 12(21):22291-22312. PubMed ID: 33188158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA PVT1 regulates growth, migration, and invasion of bladder cancer by miR-31/ CDK1.
    Tian Z; Cao S; Li C; Xu M; Wei H; Yang H; Sun Q; Ren Q; Zhang L
    J Cell Physiol; 2019 Apr; 234(4):4799-4811. PubMed ID: 30317572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Noncoding RNA Plasmacytoma Variant Translocation 1 Regulates Cisplatin Resistance via miR-3619-5p/TBL1XR1 Axis in Gastric Cancer.
    Wu C; Hu Y; Ning Y; Zhao A; Zhang G; Yan L
    Cancer Biother Radiopharm; 2020 Dec; 35(10):741-752. PubMed ID: 32407172
    [No Abstract]   [Full Text] [Related]  

  • 4. LncRNA PVT1 regulates VEGFC through inhibiting miR-128 in bladder cancer cells.
    Yu C; Longfei L; Long W; Feng Z; Chen J; Chao L; Peihua L; Xiongbing Z; Hequn C
    J Cell Physiol; 2019 Feb; 234(2):1346-1353. PubMed ID: 30076714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA DANCR promotes malignant phenotypes of bladder cancer cells by modulating the miR-149/MSI2 axis as a ceRNA.
    Zhan Y; Chen Z; Li Y; He A; He S; Gong Y; Li X; Zhou L
    J Exp Clin Cancer Res; 2018 Nov; 37(1):273. PubMed ID: 30419948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathway.
    Wang H; Niu X; Jiang H; Mao F; Zhong B; Jiang X; Fu G
    Aging (Albany NY); 2020 Aug; 12(16):16021-16034. PubMed ID: 32756011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA UCA1 promotes malignant phenotypes of renal cancer cells by modulating the miR-182-5p/DLL4 axis as a ceRNA.
    Wang W; Hu W; Wang Y; An Y; Song L; Shang P; Yue Z
    Mol Cancer; 2020 Jan; 19(1):18. PubMed ID: 31996265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA PVT1 facilitates DLBCL development via miR-34b-5p/Foxp1 pathway.
    Tao S; Chen Y; Hu M; Xu L; Fu CB; Hao XB
    Mol Cell Biochem; 2022 Mar; 477(3):951-963. PubMed ID: 35098439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of long noncoding RNA PVT1 suppresses cell proliferation and invasion of colorectal cancer via upregulation of microRNA-214-3p.
    Shang AQ; Wang WW; Yang YB; Gu CZ; Ji P; Chen C; Zeng BJ; Wu JL; Lu WY; Sun ZJ; Li D
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G222-G232. PubMed ID: 31125260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long non-coding RNA PVT1/miR-145-5p/ITGB8 axis regulates cell proliferation, apoptosis, migration and invasion in non-small cell lung cancer cells.
    Wei CM; Zhao XF; Qiu HB; Ming Z; Liu K; Yan J
    Neoplasma; 2020 Jul; 67(4):802-812. PubMed ID: 32202906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circ_0008532 promotes bladder cancer progression by regulation of the miR-155-5p/miR-330-5p/MTGR1 axis.
    Chen L; Yang X; Zhao J; Xiong M; Almaraihah R; Chen Z; Hou T
    J Exp Clin Cancer Res; 2020 May; 39(1):94. PubMed ID: 32460831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PVT1 regulates the malignant behaviors of human glioma cells by targeting miR-190a-5p and miR-488-3p.
    Xue W; Chen J; Liu X; Gong W; Zheng J; Guo X; Liu Y; Liu L; Ma J; Wang P; Li Z; Xue Y
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1783-1794. PubMed ID: 29501773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA PVT1-mediated miR-543/SERPINI1 axis plays a key role in the regulatory mechanism of ovarian cancer.
    Qu C; Dai C; Guo Y; Qin R; Liu J
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32441301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.
    Zhang Y; Wen DY; Zhang R; Huang JC; Lin P; Ren FH; Wang X; He Y; Yang H; Chen G; Luo DZ
    Cell Physiol Biochem; 2018; 47(6):2216-2232. PubMed ID: 29975928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA PVT1 contributes to cell growth and metastasis in non-small-cell lung cancer by regulating miR-361-3p/SOX9 axis and activating Wnt/β-catenin signaling pathway.
    Qi G; Li L
    Biomed Pharmacother; 2020 Jun; 126():110100. PubMed ID: 32197208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA PVT1 Regulates miR-1207-5p to Affect Colon Cancer Proliferation and Migration via the Wnt6/β-catenin2 Pathway.
    Yu P; Zhang J; Zhu A; Kong W; Shen X
    Genet Test Mol Biomarkers; 2022 Jun; 26(6):307-315. PubMed ID: 35763386
    [No Abstract]   [Full Text] [Related]  

  • 17. Upregulation of lncRNA snoRNA host gene 6 regulates NUAK family SnF1-like kinase-1 expression by competitively binding microRNA-125b and interacting with Snail1/2 in bladder cancer.
    Wang C; Tao W; Ni S; Chen Q
    J Cell Biochem; 2019 Jan; 120(1):357-367. PubMed ID: 30168179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer.
    Chen J; Yu Y; Li H; Hu Q; Chen X; He Y; Xue C; Ren F; Ren Z; Li J; Liu L; Duan Z; Cui G; Sun R
    Mol Cancer; 2019 Mar; 18(1):33. PubMed ID: 30825877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CASC9 Facilitates Cell Proliferation in Bladder Cancer by Regulating CBX2 Expression.
    Huo W; Tan D; Chen Q
    Nephron; 2020; 144(8):388-399. PubMed ID: 32570259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells.
    Tang C; Wu Y; Wang X; Chen K; Tang Z; Guo X
    Hum Cell; 2021 Mar; 34(2):588-597. PubMed ID: 33400245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.